US courts disagree on generic drug exclusivity

被引：0

|

作者：

Ken Chahine

机构：

[1] a patent attorney in Salt Lake City,

来源：

Nature Biotechnology | 1998年 / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：132 / 132

相关论文

共 50 条

[1] US courts disagree on generic drug exclusivity
Chahine, K
NATURE BIOTECHNOLOGY, 1998, 16 (02) : 132 - 132
[2] Canadian competion during a US generic drug's 180-day exclusivity period
Richard, K. M.
Shepherd, M. D.
VALUE IN HEALTH, 2007, 10 (06) : A361 - A362
[3] A Study of "Drug Entry Lags" Between Japan and the US: Compering the Timing of a New Drug Entry, Generic Entry and Market Exclusivity Periods
Masuda, Sachiko
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 321 - 321
[4] Product Exclusivity Granted by the US Food and Drug Administration
Novack, Gary D.
OCULAR SURFACE, 2016, 14 (01): : 74 - 76
[5] COURTS DISAGREE ON EXCLUSIONARY ZONING
TOMSON, B
COPLAN, N
PROGRESSIVE ARCHITECTURE, 1976, 57 (09): : 90 - 91
[6] COURTS DISAGREE ON SUBSTANTIAL AUTHORITY
BANOFF, SI
LIPTON, RM
KANTER, BW
JOURNAL OF TAXATION, 1995, 82 (06): : 380 - 381
[7] OPTIMIZING DRUG MARKET EXCLUSIVITY IN THE US AND EU MARKETS
Dahlberg, S.
Orzechowski, A. L.
Cotter, M. T.
Horowicz-Mehler, N.
VALUE IN HEALTH, 2024, 27 (06) : S200 - S200
[8] DRUG CHARACTERISTICS ASSOCIATED WITH GENERIC UPTAKE AFTER LOSS OF MARKET EXCLUSIVITY
Rome, Benjamin N.
Lee, ChangWon C.
Kesselheim, Aaron S.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S97 - S97
[9] COURTS DISAGREE ON UNDERSTATEMENT PENALTY
不详
JOURNAL OF TAXATION, 1991, 75 (05): : 335 - 336
[10] EARNING EXCLUSIVITY: GENERIC DRUG INCENTIVES AND THE HATCH-WAXMAN ACT
Hemphill, C. Scott
Lemley, Mark A.
ANTITRUST LAW JOURNAL, 2011, 77 (03) : 947 - 989

← 1 2 3 4 5 →